Medtronic completed its acquisition of Intersect ENT.
The acquisition grows Medtronic’s ENT portfolio with the Propel and Sinuva product lines, according to a May 13 news release. Intersect ENT’s subsidiary company, Fiagon, was not included in the acquisition.
The $1.1 billion acquisition was announced in August.
Here are four spinal devices that have earned FDA approval, as reported by Becker’s since Jan. 24:
The FDA has cleared Spineart’s Perla TL application for use with eCential Robotics Op.nTM robotic navigation platform. The clearance will…
Here are six key updates from spine and orthopedic companies since March 5. 1. Aurora Spine completed enrollment for its…